Enjoy this podcast from Connect: Health Tech - Live with organisational psychologist, award winning, international best-selling author, executive coach and Founder of APS Intelligence Ltd. John Amaechi OBE

Paula interviewed John to get his unique perspectives on leadership and the future of work. With his background in organisational psychology, leadership, and high-performance culture, John has empowered countless individuals and organisations to unlock their full potential.

John discusses the role of leaders and managers as giants within workplace culture - creating behaviour change and navigating successful transitions.

Listen to find out:

• How can you reframe your thinking and build the tools and knowledge to be adaptable?
• What promises has your workplace made you and is it fulfilling them?
• What changes do the next 10 years hold for the way we work?

In this episode we explore the Maxwell Centre’s Impulse programme for tech innovators that supports research translation from the perspective of Head of Entrepreneurship, Yupar Myint.

Yupar shares her career journey, from undertaking an MBA and delivering entrepreneurship programmes in Europe to leading on the development of the successful Impulse programme. Yupar gives insights into the programme format, what skills and learning participants gain and the benefits of post-programme support through networking opportunities and mentoring.

Yupar has more than 16 years of experience in building up entrepreneurship programmes and international collaborations. She has been involved in developing the IECT Hermann Hauser Summer School in Austria and has served as a programme director and mentor since 2015. Yupar worked previously at CfEL, Judge Business School where she led Ignite for over 11 years and during her leadership Ignite has generated over 250 business ventures. More than £200 million in funding was raised and approximately 4,300 jobs were created by the alumni ventures.

From 2008 to 2013, she served as a programme director at EFER in the Netherlands that trains European professors to teach entrepreneurship. Yupar completed her MBA at Cambridge Judge Business School in 2002 and her research interests include understanding the social capital effect in entrepreneurial development and training.

Yupar is passionate about developing entrepreneurial thinking and the value of mentorship throughout your career.

In this episode we explore Cambridge Judge Business School’s EnterpriseTECH and EnterpriseTECH STAR programmes as innovative programmes that support research translation from the perspective of Head of Entrepreneurial Learning Programmes Dr Rebecca Myers.

Rebecca shares her journey from being a mature student to becoming an organic chemist working in the University’s Chemistry Department for nearly 20 years to leading on the development of two successful entrepreneurship programmes that serve the research community: EnterpriseTECH and EnterpriseTECH STAR.

Rebecca gives insights into the inner workings of the programmes from their early days and how the learning and skills participants gain act as a catalyst in furthering entrepreneurial journeys.

Rebecca joined the Entrepreneurship Centre in 2018 intending to build educational programmes on entrepreneurship that serve the research community. The first was EnterpriseTECH in 2018, which has had close to 450 students attend. Then came EnterpriseTECH STAR in 2019 to help researchers begin the journey towards forming their own new ventures.

For close to 20 years, Rebecca’s home was the Department of Chemistry at the University of Cambridge. She is an organic chemist by training having done her PhD with Professor Chris Abell FRS. Rebecca then worked with Professor Steven Ley CBE FRS in the Department of Chemistry. She was also the Associate Director of the Cambridge-CRUK PhD Training Programme in Medicinal Chemistry led by Professor Sir Shankar Balasubramanian FRS for ten years. Her research and publications cover many areas of medicinal chemistry, particularly around cancer research.

Rebecca values collaborative efforts and is passionate about cultivating meaningful research impact and creating opportunities for researchers to thrive beyond academia.

In this episode we explore innovative programmes that support research translation.

Broderick House, a previous participant of the Cambridge Judge Business School’s EnterpriseTECH and EnterpriseTECH STAR programmes, gives us insights into his experience of taking part and into the programme content. Broderick also discusses his new spin-out venture and navigating the Cambridge innovation ecosystem.

Broderick is a Harding Distinguished Postgraduate Scholar in the Department of Zoology at the University of Cambridge. Based in the Aquatic Ecology Group, Broderick’s research interests include aquaculture, bivalves, public health and food security.

His research work will leverage emerging technologies in bivalve aquaculture production to develop closed systems allowing urban settings, including currently untapped land-locked areas, to produce safe, fast-growing, sustainable bivalve products.

In this episode of Joining the Dots we explore the Interdisciplinary Research Collaboration group and their approach to developing new technologies for hard-to-treat cancers.

The EPSRC Interdisciplinary Research Collaboration (IRC) in Targeted Delivery for Hard-to-Treat Cancers aims to develop new technologies to effectively deliver drugs for the treatment of three hard-to-treat cancers: in the pancreas, brain, and chest.

The guests for this podcast are two of the IRC investigators: Professor Colin Watts, Chair and Professor of Neurosurgery at the Brain Cancer Programme at the University of Birmingham, and Dr Ronan Daly, Associate Professor in the Science and Technology of Manufacturing at the University of Cambridge’s Institute for Manufacturing.

Listen on to hear Colin and Ronan talk about how manufacturing research is helping to overcome the challenges of delivering effective cancer treatments and the opportunities to use the same technologies for other diseases or conditions.

The overarching aim of the IRC is to develop and validate high-capacity vehicles, injectable gels, and implantable devices to better target hard-to-treat cancers, enhancing treatment efficacy by increasing the rate and extent of drug activity at the tumour site. The programme has been designed to facilitate effective translation from the laboratory to the clinic by incorporating cross-cutting validation and manufacturing themes across all the technologies.

ABOUT THE GUESTS

Professor Colin Watts

Professor of Neurosurgery, Chair Birmingham Brain Cancer Programme, University of Birmingham

Honorary Consultant Neurosurgeon, University Hospitals Birmingham

Colin leads the newly established Brain Cancer Programme at the University of Birmingham. His research aims to improve the treatment and survival of patients with glioma by understanding the molecular genetic heterogeneity of individual tumours and using that data to develop novel molecular and functional stratification suitable for application in clinical trials. His clinical practice specializes in neurosurgical oncology with a particular interest in intrinsic gliomas and cerebral metastases.

Dr Ronan Daly

Associate Professor, Science and Technology of Manufacturing, Institute for Manufacturing, University of Cambridge

Ronan is a Course Director for the Manufacturing Engineering course, where students learn about manufacturing technologies and manufacturing management. He previously worked in Unilever R&D before completing a PhD in Chemistry from the School of Chemistry and Centre for Research on Adaptive Nanostructures and Nanodevices at Trinity College Dublin. He leads the Fluids in Advanced Manufacturing research group at the IfM, which tackles fluid flow and functional material challenges to enable scale-up of advanced manufacturing technologies.

In this episode we explore innovative programmes that support research translation.

Coco Newton, a previous participant in Cambridge Judge Business School’s Enterprise Tech and Enterprise TechStar programmes, gives us an insight into how they work and her experience of taking part. Coco also discusses her new spin-out venture and navigating the Cambridge innovation ecosystem.

Coco is a neuroscientist focused on creating new cognitive markers that can help detect Alzheimer's disease years before dementia onset. Coco is currently working as a post-doctoral research fellow in the global EDoN (Early Detection of Neurodegeneration) initiative, spearheaded by Alzheimer's Research UK and Gates Ventures.

Coco completed a PhD in Clinical Neuroscience at the University of Cambridge as a Cambridge Trust Scholar. Her research work investigates novel cognitive outcome measures for preclinical stages of Alzheimer’s disease using immersive virtual reality tests of navigation. As part of the Cambridge Judge Business School Accelerate programme she is co-founding a spin-out to continue clinical development of these navigation assessments.

Outside of her work, Coco is undertaking the RYA Yachtmaster skipper qualification and holds a Cambridge Blue in lightweight rowing.

In this episode we explore research commercialisation from an NHS perspective. Navigating the NHS healthcare system can be a daunting prospect for an innovator. Dr Louise Jopling, Commercial Director at the Eastern Academic Health Science Network, explains the routes available for those to looking to have their technology adopted into the NHS.

Louise leads the commercial team at EAHSN to develop partnerships and support innovators to refine their business models and value propositions to ensure commercial sustainability.

Louise holds a PhD in immunology from Imperial College London and drawing on both her background in science and years of experience in drug discovery, development and commercialisation within academia, biotech and pharmaceutical organisations, she leads the commercial team to develop partnerships and support innovators to refine their business models and value propositions to ensure commercial sustainability.

Louise joined Eastern AHSN from Johnson and Johnson Innovation, where she led partnership activities across Europe, Middle East and Africa to identify and incubate external assets and capabilities to advance the portfolio of the Immunology Therapy Area for Janssen.

Louise is an advisory board member for MedTech Integrates conference, a mentor on a number of accelerator programmes including Accelerate Cambridge (Judge Business School) and Start Codon. She is also a long-standing member of the British Society for Immunology.

In this bitesize podcast, Anita Marguerie de Rotrou, Head of the Office for Translational Research, shares advice and guidance on routes for translating research, including

- the support OTR can provide

- the benefits of engaging specialist support for research translation

- a successful project supported by OTR that uses AI to detect heart valve disease (acoustics.eng.cam.ac.uk/2022/05/25/in…-on-bbc-news/).

Dr Anita Marguerie de Rotrou is Head of Cambridge University’s Office for Translational Research, strategically setting the vision of the OTR with stakeholders, managing the team, and overseeing the overall project portfolio. With a PhD in developmental biology (UCL), a postdoc at Cancer Research UK, and 10 years’ experience in SMEs at operational, management, and scientific levels, her expertise notably includes setting up start-ups from scratch, product development, fundraising from investors, government, EU, public, and private sectors. She joined the OTR in 2015 and was appointed as Head two years later.